Technical Analysis for APLI - Appili Therapeutics Inc

Grade Last Price % Change Price Change
D 0.030 0.00% 0.000
APLI closed unchanged on Wednesday, March 27, 2024, on 57 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%

   Recent Intraday Alerts

Alert Time
Gap Down Closed about 23 hours ago
Lower Bollinger Band Support about 23 hours ago
Reversed from Down about 23 hours ago
Gapped Down (Full) about 24 hours ago
Down 1 ATR about 24 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Appili Therapeutics Inc Description

Appili Therapeutics Inc is a Canada-based anti-infective pharmaceutical development company. The Company focuses on identifying, acquiring and advancing therapeutics for infectious disease. The Company is engaged in developing strategies to develop new classes of antibiotics and anti-infectives to the clinic to improve treatment and health of patients suffering from infection. The Company has over two anti-infective programs, which include ATI-1501 and ATI-1503. The Company's ATI-1501 is a taste-masked treatment for clostridium difficile infection. The Company's ATI-1503 is an antibiotic with a potential to treat Gram-negative infections, such as Klebsiella pneumoniae. The Company’s agents focus on the therapeutics, including antivirals, antifungals, antiparasitics and antimicrobials, which can treat the hospital and community acquired infections caused by multi-drug resistant pathogens.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Pharma Pharmaceutical Clinic Drug Disease Bacteria Infection Antibiotic Antimicrobial Anti Infectives Antibiotics Organisms Antivirals Biocides Infections Infectious Disease

Is APLI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.08
52 Week Low 0.025
Average Volume 120,525
200-Day Moving Average 0.040
50-Day Moving Average 0.031
20-Day Moving Average 0.032
10-Day Moving Average 0.033
Average True Range 0.003
RSI (14) 46.81
ADX 16.88
+DI 22.760
-DI 41.889
Chandelier Exit (Long, 3 ATRs) 0.031
Chandelier Exit (Short, 3 ATRs) 0.034
Upper Bollinger Bands 0.039
Lower Bollinger Band 0.025
Percent B (%b) 0.35
BandWidth 41.250
MACD Line 0.000
MACD Signal Line 0.001
MACD Histogram -0.0005
Fundamentals Value
Market Cap 1.87 Million
Num Shares 62.3 Million
EPS -0.15
Price-to-Earnings (P/E) Ratio -0.20
Price-to-Sales 280.78
Price-to-Book 3.58
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.038
Resistance 3 (R3) 0.037 0.033 0.036
Resistance 2 (R2) 0.033 0.031 0.034 0.036
Resistance 1 (R1) 0.032 0.030 0.033 0.033 0.035
Pivot Point 0.028 0.028 0.029 0.029 0.028
Support 1 (S1) 0.027 0.026 0.028 0.028 0.025
Support 2 (S2) 0.023 0.025 0.024 0.024
Support 3 (S3) 0.022 0.023 0.024
Support 4 (S4) 0.023